Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2Sarcoma 1

Conditions

Osteosarcoma 1Neuroectodermal Tumors, Primitive 1Liver Neoplasms 1Hearing Loss 1

Interventions

Filgrastim 4Carboplatin 4Thiotepa 3pembrolizumab 2ixabepilone 2Temozolomide 2Riluzole 2Radiotherapy 2Peripheral Blood Stem Cell Transplantation 2Oncolytic Virotherapy 2Melphalan 2Ipilimumab 2Ifosfamide 2Granulocyte Colony-Stimulating Factor 2Etoposide 2Drug Therapy 2Cyclophosphamide 2Busulfan 2trastuzumab deruxtecan 1spartalizumab 1sodium thiosulfate 1sargramostim 1pazopanib 1fludarabine 1etoposide phosphate 1Topotecan 1Thrombopoietin 1Tamoxifen 1Stem Cell Transplantation 1Restraint, Physical 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Liver Neoplasms × Acetylcysteine × Sarcoma × Clear all
NCT02094625 2023-04-18

NAC to Prevent Cisplatin-induced Hearing Loss

Children's Hospital Los Angeles

Phase 1 Completed
52 enrolled
GastrointestinalSarcoma

Liver Neoplasms, Osteosarcoma, Neuroectodermal Tumors, Primitive, Hearing Loss

Data powered by HemOnc (CC BY 4.0) Colophon âš¡